GlassScriptPhysician profile
Sendhil Subramanian
NPI 1902883168
$17,114.77
in general payments reported to CMS, 2019-2025
18 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,081 · 2020: $1,007 · 2021: $2,631 · 2022: $11K · 2023: $454 · 2024: $193 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $12,031.66 | 2021-2023 | Auryon Laser System 100-120 Vac |
| Sirtex Medical INC | $1,671.33 | 2019-2022 | |
| Novo Nordisk INC | $1,086.72 | 2019-2025 | |
| Galt Medical | $423.02 | 2019 | |
| Smith+Nephew, INC. | $361.69 | 2019-2022 | |
| Philips North America LLC | $325.45 | 2019-2022 | |
| Cardiva Medical, INC. | $249.40 | 2019 | |
| Osiris Therapeutics INC. | $223.74 | 2019 | |
| Siemens Medical Solutions USA, INC. | $221.92 | 2021-2024 | Embozene |
| Abbott Laboratories | $180.21 | 2023 | Diamondback Peripheral |
| Cordis US Corp. | $80.65 | 2024-2025 | Mynx Control |
| Vasorum USA INC. | $75.00 | 2023 | Celt Acd |
| Avantec Vascular Corporation | $67.20 | 2023 | |
| Biocompatibles, INC. | $33.28 | 2019 | |
| Boston Scientific Corporation | $31.68 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $20.24 | 2022 | |
| Cook Medical LLC | $17.08 | 2022 | |
| Venclose INC. | $14.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sendhil Subramanian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.